Physician profile
Jenna Lopez
NPI 1255903498
$596.73
in general payments reported to CMS, 2019-2025
16 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $137 · 2022: $42.90 · 2023: $107 · 2024: $84.59 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $136.90 | 2021 | |
| Lucid Diagnostics INC. | $63.27 | 2022-2023 | |
| Cranial Technologies, INC | $60.21 | 2023-2025 | Doc Band |
| Intra-Sana Laboratories | $39.30 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Novo Nordisk INC | $38.46 | 2023-2025 | Rybelsus |
| Merck Sharp & Dohme LLC | $37.52 | 2025 | Vaxelis, Gardasil 9, Rotateq |
| Seqirus USA INC | $34.53 | 2025 | Fluad, Flucelvax |
| Viiv Healthcare Company | $26.73 | 2022 | |
| Corium, LLC | $25.39 | 2024 | Azstarys |
| Pfizer INC. | $24.42 | 2024 | |
| Abbvie INC. | $21.88 | 2025 | |
| Daiichi Sankyo INC. | $20.68 | 2025 | Injectafer |
| Glaxosmithkline, LLC. | $17.83 | 2023 | Bexsero |
| Amgen INC. | $17.50 | 2025 | Otezla, Repatha |
| Exact Sciences Corporation | $16.65 | 2025 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.46 | 2024 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.